Article
Requirement for deoxycytidine kinase in T and B lymphocyte development
31 Dec 2009
Abstract excerpt
Deoxycytidine kinase (dCK) is a rate-limiting enzyme in deoxyribonucleoside salvage, a metabolic pathway that recycles products of DNA degradation. dCK phosphorylates and therefore activates nucleoside analog prodrugs frequently used in cancer, autoimmunity, and viral infections. In contrast to its well established therapeutic relevance, the biological function of dCK remains enigmatic. Highest levels of dCK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
